|
|
腔内治疗急性下肢深静脉血栓的治疗发展
|
Abstract:
下肢深静脉血栓(DVT)是指血液在深静脉内凝结导致管腔部分或完全堵塞，其发病率随年龄的增长而增加。DVT可因肺动脉栓塞(PE)、反常栓塞、血栓后综合征(PTS)而导致患者残疾、功能状态丧失，造成巨大心理和经济上的负担。LEDVT需要可行的、有效的及安全的治疗来改善症状和挽救患肢，所以及时清除静脉血栓，恢复静脉瓣膜的功能，并减少相应并发症的发生尤为重要。近年来DVT传统的治疗方法抗凝药物保守治疗或外科手术取栓治疗逐步被腔内介入技术所逐渐取代，腔内介入治疗技术具有微创、高效等优势，并发症发生率相对较低。现就腔内介入治疗的进展予以综述。
Lower extremity thrombosis (DVT) refers to partial or complete occlusion of the lumen caused by blood coagulation in deep veins. The incidence of DVT increases with age. DVT can result in disabil-ity, functional loss and great psychological and economic burden due to pulmonary embolism (PE), anomalous embolism and post-thrombotic syndrome (PTS). LEDVT needs feasible, effective and safe treatment to improve the symptoms and salvage the affected limb, so it is important to clear the venous thrombus, restore the function of venous valve and reduce the occurrence of the corre-sponding complications. In recent years, the traditional treatment of DVT, conservative anticoagu-lant therapy or surgical embolectomy, has been gradually replaced by endovascular interventional therapy, which has the advantages of minimal invasion and high efficiency, the incidence of compli-cations was relatively low. This article reviews the progress of endovascular interventional therapy.
| [1] | 王晓天, 焦健, 张邓, 彭剑波. 下肢深静脉血栓后综合征的腔内治疗进展[J]. 血管与腔内血管外科杂志, 2022, 8(10): 1217-1220. https://doi.org/10.19418/j.cnki.issn2096-0646.2022.10.15 |
| [2] | 朱威, 卢冉, 孙浩博, 章良. 一期或分期行腔内治疗对下肢深静脉血栓合并髂静脉压迫综合征患者疗效的影响[J]. 广西医学, 2022, 44(13): 1457-1461. |
| [3] | 朱威. 下肢深静脉血栓合并髂静脉病变一期和分期腔内治疗疗效对比研究[D]: [硕士学位论文]. 蚌埠: 蚌埠医学院, 2022. https://doi.org/10.26925/d.cnki.gbbyc.2022.000058 |
| [4] | 董训忠, 秦金保, 崔健, 石亿, 周汝航. 经皮导管接触溶栓腔内治疗与标准抗凝治疗用于急性下肢深静脉的临床效果比较[J]. 现代生物医学进展, 2019, 19(18): 3589-3593, 3597. https://doi.org/10.13241/j.cnki.pmb.2019.18.042 |
| [5] | Furfaro, D., Ste-phens, R.S., Streiff, M.B. and Brower, R. (2018) Catheter-Directed Thrombolysis for Intermediate-Risk Pulmonary Em-bolism. Annals of the American Thoracic Society, 15, 134-144.
https://doi.org/10.1513/AnnalsATS.201706-467FR |
| [6] | Abraham, B., Sedhom, R., Megaly, M., et al. (2021) Outcomes with Catheter-Directed Thrombolysis Compared with Anticoagulation Alone in Patients with Acute Deep Ve-nous Thrombosis. Catheterization and Cardiovascular Interventions, 97, E61-E70. https://doi.org/10.1002/ccd.29226 |
| [7] | Razavi, M.K., Salter, A., Goldhaber, S.Z., et al. (2020) Correlation between Post-Procedure Residual Thrombus and Clinical Outcome in Deep Vein Thrombosis Patients Receiving Pharmacome-chanical Thrombolysis in a Multicenter Randomized Trial. Journal of Vascular and Interventional Radiology, 31, 1517-1528.
https://doi.org/10.1016/j.jvir.2020.07.010 |
| [8] | Comerota, A.J., Kearon, C., Gu, C.S., et al. (2019) Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis. Circulation, 139, 1162-1173. https://doi.org/10.1161/CIRCULATIONAHA.118.037425 |
| [9] | Mastoris, I., Kokkinidis, D.G., Bikakis, I., et al. (2019) Catheter-Directed Thrombolysis vs Anticoagulation for the Prevention and Treatment of Post-Thrombotic Syn-drome in Deep Vein Thrombosis: An Updated Systematic Review and Meta-Analysis of Randomized Trials. Phlebology, 34, 675-682. https://doi.org/10.1177/0268355519835618 |
| [10] | Haig, Y., Enden, T., Gr？tta, O., et al. (2016) Post-Thrombotic Syndrome after Catheter-Directed Thrombolysis for Deep Vein Thrombosis (CaVenT): 5-Year Fol-low-up Results of an Open-Label, Randomised Controlled Trial. Lancet Haematol, 3, E64-E71. https://doi.org/10.1016/S2352-3026(15)00248-3 |
| [11] | Kahn, S.R., Julian, J.A., Kearon, C., et al. (2020) Quality of Life after Pharmacomechanical Catheter-Directed Thrombolysis for Proximal Deep Venous Thrombosis. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 8, 8-23.e18. |
| [12] | Vedantham, S., Goldhaber, S.Z., Julian, J.A., et al. (2017) Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis. The New England Journal of Medicine, 377, 2240-2252.
https://doi.org/10.1056/NEJMoa1615066 |
| [13] | 刘辉, 承文龙, 卢辉俊. 导管溶栓与系统溶栓治疗急性下肢深静脉血栓形成的Meta分析[J]. 中国血管外科杂志(电子版), 2016, 8(3): 183-187. |
| [14] | 余汁, 单平, 楼新江, 等. 多种入路治疗下肢深静脉血栓形成比较分析[J]. 心电与循环, 2017, 36(2): 105-107, 109. |
| [15] | 肖亦明, 范惠双, 莫灿均, 曾汉强, 张志成, 谭志斌. 急性下肢深静脉血栓形成腔内治疗的中远期疗效观察[J]. 中华介入放射学电子杂志, 2019, 7(3): 222-226. |
| [16] | 刘宝坤, 周栋, 屈睿升, 郭婷婷, 顾浩. 急性下肢深静脉血栓的腔内治疗进展[J]. 临床放射学杂志, 2022, 41(3): 571-574. https://doi.org/10.13437/j.cnki.jcr.2022.03.002 |
| [17] | 朱红江, 张燕, 杨志勇, 刘琳, 刘明阳. 腔内治疗下肢深静脉血栓形成的临床效果观察[J]. 解放军医药杂志, 2019, 31(6): 65-68. |
| [18] | 潘晶晶, 张希全. 急性下肢深静脉血栓的诊断与腔内治疗进展[J]. 实用医药杂志, 2014(6): 550-552.
https://doi.org/10.14172/j.cnki.issn1671-4008.2014.06.042 |
| [19] | 潘晶晶, 张希全. 急性下肢深静脉血栓的腔内治疗现状及进展[J]. 医学综述, 2013, 19(20): 3726-3728. |
| [20] | 李维敏, 陆信武. 腔内治疗髂静脉受压综合征合并急性下肢深静脉血栓的近期疗效[J]. 中华临床医师杂志(电子版), 2012(7): 1911-1913. |
| [21] | 潘晓琳, 朱成河, 张希全, 张丽丽, 王婷婷, 邱为为. 多种介入技术联合腔内治疗下肢深静脉血栓临床护理[J]. 当代医学, 2009, 15(23): 483-484. |
| [22] | 王志鹏, 赵德信, 赵玉欣, 杨绪鹏, 何坤, 靳嵩, 张明浩, 黄城督. 腔内介入技术治疗下肢深静脉血栓的研究进展[J]. 中国医药科学, 2022, 12(21): 68-71. |
| [23] | 姜广伟, 丁殿柱, 张晓宇, 牛帅, 吕柏楠. 一站式腔内介入治疗髂静脉压迫综合征继发下肢深静脉血栓疗效观察[J]. 浙江大学学报(医学版), 2022, 51(3): 341-349. |
| [24] | 林晓东, 杨红伟, 王祖辉, 郭娟娟, 李涛, 张岩, 余文水, 林环, 刘培娟, 冯玲, 朱国献. 经不同入路腔内治疗下肢深静脉血栓形成的近期疗效比较[J]. 中国血管外科杂志(电子版), 2020, 12(4): 319-323. |
| [25] | Garcia, M.J., Lookstein, R., Malhotra, R., et al. (2015) Endovascular Management of Deep Vein Throm-bosis with Rheolytic Thrombectomy: Final Report of the Prospective Multicenter PEARL (Peripheral Use of AngioJet Rheolytic Thrombectomy with a Variety of Catheter Lengths) Registry. Journal of Vascular and Interventional Radiology, 26, 777-785. https://doi.org/10.1016/j.jvir.2015.01.036 |
| [26] | Mahnken, A.H., Thomson, K., de Haan, M. and O’Sullivan, G.J. (2014) CIRSE Standards of Practice Guidelines on Iliocaval Stenting. CardioVascular and Interven-tional Radiology, 37, 889-897.
https://doi.org/10.1007/s00270-014-0875-4 |
